DOBUTAMINE HYDROCHLORIDE
- Product NDC
- 51662-1566
- 11-digit product format
- 516621566
- Labeler code
- 51662
- Product ID
- 51662-1566_1035c14e-d1ea-8603-e063-6394a90a430b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOBUTAMINE HYDROCHLORIDE
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Application
- NDA020255
- Marketing category
- NDA
- Marketing start
- 2021-07-10
- Substance
- DOBUTAMINE HYDROCHLORIDE
- Active strength
- 100 mg/100mL
- Pharmacologic classes
- Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOBUTAMINE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOBUTAMINE HYDROCHLORIDE | 100 mg/100mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0WR771DJXV |
| Rxcui | 309985 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1566-1 | DOBUTAMINE HYDROCHLORIDE | 250 mL in 1 BAG | INJECTION | 250 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1566 | DOBUTAMINE HYDROCHLORIDE INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240201_c6ceb8d3-e46e-f0da-e053-2995a90a8c3c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1566-1 | 51662156601 | 250 mL in 1 BAG (51662-1566-1) | 250 ml | 2021-07-10 | 0000-00-00 | No | No | Current |